Therefore, NCAPD3 knockdown may inhibit CCND1, MYC, and ESR1 activity to downregulate CDK6 and IRS1 expression, thereby inhibiting the proliferation of gastric cancer cells. This evidence concerns the gene ESR1 and gastric cancer.